Primary Biatrial Cardiac Rhabdomyosarcoma

Uchida, Tetsuro; Kuroda, Yasuhiro; Sadahiro, Mitsuaki

doi:10.21470/1678-9741-2018-0414

Cited by 6 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Rhabdomyosarcoma, which was first described by Raycoff in 1937, is a malignant tumor arising from embryonic mesenchymal cells that can differentiate into skeletal muscle [1]. The literature shows that cardiac sites involved include the left atrium (55%), left ventricle (15.7%), right ventricle (15.7%), and right atrium (13%) [3].…”

Section: Discussionmentioning

confidence: 99%

“…They may present with tumor-induced cerebral, pulmonary and peripheral embolism. Among these patients, survival with surgical resection is around six months to one year [3]. Although complete surgical resection is the most important prognostic factor, systemic chemotherapy and local radiotherapy for residual tumors are both important for possible survival [1].…”

Section: Discussionmentioning

confidence: 99%

“…Primary cardiac tumors are rare and have been reported at between 0.001% and 0.28% in autopsy series [1]. Of these primary tumors, 25% are malignant [2,3]. Rhabdomyosarcoma accounts for 20% of these malignant tumors [4,5].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Recurrent cardiac rhabdomyosarcoma with multiple metastases: A case report

Reyhanoglu¹,

Edem²,

Ozcan³

et al. 2022

J Surg Med

View full text Add to dashboard Cite

Rhabdomyosarcoma, which accounts for 20% of all malignant tumors of the heart, is an aggressive tumor originating in the ventricular wall. These tumors are the second most common malignant primary tumor of the heart after angiosarcoma. Despite treatment options, such as surgical resection, radiotherapy, and chemotherapy, recurrence is common and mortality is high. Among these patients, survival with surgical resection is around six months to one year. In this case report, we discuss a patient who presented with recurrent rhabdomyosarcoma with distant metastasis after surgical intervention. A 56-year-old male patient who underwent left atrial mass excision and mitral valve replacement ten months prior was admitted with recurrent metastatic rhabdomyosarcoma.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Recurrent cardiac rhabdomyosarcoma with multiple metastases: A case report

Reyhanoglu¹,

Edem²,

Ozcan³

et al. 2022

J Surg Med

View full text Add to dashboard Cite

show abstract

“…Se discutió el caso del paciente en reunión clínica El pronóstico prequirúrgico varía según edad, síntomas de descompensación hemodinámica y grado de malignidad (5) . En varias revisiones se sugiere cirugía del tumor primario e incluso se menciona el trasplante autólogo, no existe un procedimiento específico (8) , otras terapias utilizadas para la adyuvancia son la quimioterapia y la radioterapia (9,10) .…”

Section: Reporte De Caso / Case Reportunclassified

Rabdomiosarcoma cardiaco: a case report from the Clinical Oncology Service of the Instituto de Previsión Social (IPS)

Zacaria

Pereira²,

Arévalos³

et al. 2022

Rev. salud publica Parag

View full text Add to dashboard Cite

Recibido el 17 de agosto de 2021, aprobado para publicación el 02 de diciembre 2021 INTRODUCCIÓNLos tumores benignos a nivel cardiaco son comunes y por orden de frecuencia son: rabdomioma, fibroma, mixoma, teratoma, hemangioma y otros (1) . Los tumores cardíacos primarios malignos son infrecuentes, entre los sarcomas publicados son el angiosarcoma , sarcomas pleomórficos indiferenciados y el rabdomiosarcoma (2) .El rabdomiosarcoma es una neoplasia maligna que muestra la diferenciación del esqueleto, tiene baja incidencia (0.002% a 0.3%) en la población infanto-juvenil y adulta, siendo más infrecuente su aparición en la etapa adulta. Afectan principalmente el lado derecho del corazón, especialmente el miocardio. Se caracteriza por crecer rápidamente y afectar ambos lados cardiacos y estructuras adyacentes, produciendo múltiples tumores y se diseminan vía hematógena o por continuidad (3) .

show abstract